Human umbilical cord mesenchymal stem cell cryopreservation liquid and application thereof

By adding frozen liquid of Scutellaria baicalensis or Cervical extract to the basal culture medium, the problems of short freezing time and low survival rate of human umbilical cord mesenchymal stem cells are solved, significantly prolonging the freezing time and improving survival rate. Meets actual production needs.

CN119032935APending Publication Date: 2024-11-29广东壹加再生医学研究院有限公司
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411149034.7
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-21
Publication Date
2024-11-29

AI Technical Summary

Technical Problem

The prior art is difficult to effectively extend the freezing time of human umbilical cord mesenchymal stem cells, and the survival rate after freezing is low, making it difficult to meet actual production needs.

Method used

Add Scutellaria baicalensis extract or Cervical extract to the basal culture medium to form a frozen liquid of human umbilical cord mesenchymal stem cells, improving the freezing time and survival rate of cells.

Benefits of technology

By adding specific concentrations of plant extracts, the freezing time of cells is significantly extended and the survival rate after freezing is improved. In particular, Scutellaria baicalensis extract and Cervical extract can maintain cell survival rate at 85% under specific addition amounts. % or more to 30 months.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0005003077100000041
    Figure BDA0005003077100000041
  • Figure BDA0005003077100000051
    Figure BDA0005003077100000051
Patent Text Reader

Abstract

The invention provides a human umbilical cord mesenchymal stem cell cryopreservation solution and application thereof, and belongs to the technical field of mesenchymal stem cell preservation. The human umbilical cord mesenchymal stem cell cryopreservation liquid provided by the invention comprises a basic culture medium and a plant extract, the basic culture medium is prepared from DMEM / F12, DMSO (Dimethylsulfoxide) and PBS (Phosphate Buffer Solution), and the volume ratio of the DMEM / F12 to the DMSO to the PBS is (40 to 60) to (5 to 10) to (30 to 50); the plant extract is a radix scutellariae extract or a semen plantaginis extract. According to the human umbilical cord mesenchymal stem cell cryopreservation liquid provided by the invention, the plant extract is added on the basis of the basic cryopreservation culture medium, so that the survival rate of hUC-MSC is increased, and the cryopreservation time of the hUC-MSC is prolonged.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the technical field of mesenchymal stem cell preservation, and in particular to a human umbilical cord mesenchymal stem cell cryopreservation solution and application thereof. Background Art

[0002] Mesenchymal stem cells (MSCs) originate from the early mesoderm of development. They are multipotent stem cells with high self-renewal ability, high proliferation ability and multidirectional differentiation potential. They are widely found in various tissues such as bone marrow, fat, umbilical cord blood, and umbilical cord. Among them, umbilical cord MSCs are rich in content and have stronger functions, becoming an important source for MSC research. However, excessive subculture of human umbilical cord mesenchymal stem cells (hUC-MSCs) will cause severe aging and apoptosis, and long-term in vitro culture is prone to spontaneous differentiation, losing multidirectional differentiation potential, resulting in a waste of hUC-MSC resources.

[0003] At present, hUC-MSCs are generally preserved by cryopreservation, which generally involves first cooling to -80°C and then immersing in liquid nitrogen at -196°C. Wang Jun et al. cryopreserved hUC-MSCs under this condition and used DMEM / F12 medium containing 10% DMSO and 40% FBS as the cryopreservation medium. After 6 months of cryopreservation, hUC-MSCs were revived and the survival rate was 96.57%, which was not much different from the 97.32% before cryopreservation. (See Wang Jun, Kong Weixia, Xu Man, et al. Effects of cryopreservation on the biological characteristics of human umbilical cord mesenchymal stem cells [J]. Journal of the Military Postgraduate Medical School, 2012, 33(11):5. DOI:10.3969 / j.issn.1005-1139.2012.11.021.). However, the cryopreservation time of this method is relatively short, only 6 months, which is difficult to meet the actual production needs. However, the cryopreservation fluid is related to the cryopreservation time and cryopreservation performance of hUC-MSC. Li Tian et al. used different cryopreservation fluids to preserve hUC-MSC, and the cryopreservation time could be extended to 12 months. However, even with the optimal cryopreservation fluid, the cell survival rate after recovery could only reach about 85%. (See Li Tian, ​​Li Xiaomao, Chen Shaohong, et al. Effects of different cryopreservation fluids on the biological characteristics of human umbilical cord mesenchymal stem cells [J]. Organ Transplantation, 2013, 4(5): 6. DOI: 10.3969 / j.issn.1674-7445.2013.05.006.). Therefore, it is necessary to optimize the cryopreservation fluid of hUC-MSC to better preserve the function of hUC-MSC.

[0004] Traditional Chinese medicine is a treasure of the Chinese nation and has a history of thousands of years of use, of which botanicals account for the majority. With the deepening of research, the use of traditional Chinese medicine is no longer limited to curing diseases and saving lives. Traditional Chinese medicine extracts are the "essence" concentrated by solvent extraction based on traditional Chinese medicine raw materials. They contain a variety of active ingredients and have a wide range of functions. Wang Yan et al. used astragalus extract to cryopreserve primary human fetal liver cells ([1] Wang Yan, Zhu Yingqian, Lin Jingming, et al. Protective effect of astragalus extract on cryopreserved primary human fetal liver cells [J]. Chinese Medicinal Materials, 2007, 30(012): 1551-1554. DOI: 10.3321 / j.issn:1001-4454.2007.12.023.). Therefore, it is feasible to develop plant extracts to protect human umbilical cord mesenchymal stem cells from cryopreservation. Summary of the invention

[0005] The purpose of the present invention is to provide a cryopreservation solution for human umbilical cord mesenchymal stem cells, which solves the problems of short cryopreservation time and low survival rate of hUC-MSC after cryopreservation.

[0006] In order to achieve the above-mentioned object of the invention, the present invention provides the following technical solutions:

[0007] The present invention provides a human umbilical cord mesenchymal stem cell cryopreservation solution, comprising a basic culture medium and a plant extract;

[0008] The basic culture medium comprises DMEM / F12, DMSO and PBS, and the volume ratio of DMEM / F12, DMSO and PBS is 40-60:5-10:30-50;

[0009] The plant extract is a scutellaria baicalensis extract or a plantain seed extract.

[0010] Preferably, the added amount of the Scutellaria baicalensis extract is 5 to 20 mg / L of the volume of the basal culture medium.

[0011] Preferably, the amount of the Plantago seed extract added is 50-70 mg / L of the volume of the basal culture medium.

[0012] Preferably, the method for preparing the scutellaria baicalensis extract or the plantago asiatica extract comprises the following steps:

[0013] (1) soaking dried Scutellaria baicalensis root or dried Plantago asiatica seed in water, filtering out water after soaking, and grinding to obtain Scutellaria baicalensis root powder or Plantago asiatica seed powder;

[0014] (2) adding water to a slurry of scutellaria baicalensis powder or a slurry of plantain seed powder and boiling the mixture, separating the solid from the liquid, and obtaining a filtrate;

[0015] (3) The filtrate is concentrated and then dried to obtain a scutellaria baicalensis extract or a plantain seed extract.

[0016] Preferably, the amount of water added for soaking is 5 to 10 times the mass of the dried root of Scutellaria baicalensis or the dried Plantago asiatica; and the soaking time is 6 to 8 hours.

[0017] Preferably, when decocting with water, the volume ratio of Scutellaria baicalensis powder slurry or Plantago seed powder slurry to water is 1:3-5, and the decocting time is 30-60 min.

[0018] The present invention also provides an application of the cryopreservation solution in cryopreserving human umbilical cord mesenchymal stem cells.

[0019] The cryopreservation solution of human umbilical cord mesenchymal stem cells provided by the present invention is based on the basic cryopreservation medium, and plant extracts are added, especially scutellaria baicalensis extract and plantain seed extract are added to improve the survival rate of hUC-MSC and extend the cryopreservation time of hUC-MSC, thereby solving the problems of short cryopreservation time of hUC-MSC and low survival rate after cryopreservation. DETAILED DESCRIPTION

[0020] The technical solutions provided by the present invention are described in detail below in conjunction with the embodiments, but they should not be construed as limiting the protection scope of the present invention.

[0021] Example 1

[0022] 1. Preparation of P3 human umbilical cord mesenchymal stem cells

[0023] The umbilical cord was obtained from healthy pregnant women at full term, and the women gave their informed consent and signed a consent form.

[0024] Rinse the umbilical cord with PBS under sterile conditions, then cut it into 3-5 cm segments, rinse it again with PBS to remove residual blood, and then cut it into 1 mm segments. 3 The cells were washed in small pieces and placed in a culture dish. 0.2% trypsin was added and digested at 37°C for 1 h. After digestion was stopped, the cell suspension was filtered to obtain a cell suspension. The cell suspension was centrifuged (300 rpm, 25 min) to obtain a cell pellet. The cell pellet was washed twice with PBS, the supernatant was discarded, and the cell concentration was resuspended in DMEM / F12 medium containing 10% FBS to a concentration of 1×10 5 / mL, then take 5mL and add to 75cm 2 Add 100U / mL penicillin and 100U / mL streptomycin to the culture flask. Place in an incubator at 37°C, 5% CO2, humidity>95%, change the medium every 48 hours, and culture until the cell confluence reaches more than 90%, then perform subculture. Subculture at a ratio of 1:2 to obtain P3 generation hUC-MSCs for later use.

[0025] 2. Preparation of Plant Extracts

[0026] The plants used in the experiment are Astragalus, Scutellaria, Lycium barbarum and Plantago.

[0027] Take dried root of Astragalus, dried root of Scutellaria, dried fruit of Lycium barbarum, and dried Plantago respectively, add 8 times of their respective weight of water, soak at room temperature (28°C) for 7 hours, then use gauze (2 layers) to filter out the water, grind the soaked Chinese medicines separately, the grinding speed is 6000r / min, and grind for 5 minutes to obtain each Chinese medicine slurry.

[0028] Take each Chinese medicine slurry and add 4 times the volume of water, boil it and maintain it for 45 minutes, filter it with gauze (4 layers) to obtain filtrate 1, filter filtrate 1 to obtain filtrate 2, and ultrafilter filtrate 2 through a 0.22μm filter to obtain filtrate 3.

[0029] The filtrate 3 was concentrated and dried at 60°C to obtain Chinese medicine powder, which was crushed and passed through a 100-mesh sieve to obtain astragalus extract, scutellaria baicalensis extract, wolfberry extract, and plantain extract for later use.

[0030] 3. Prepare cryopreservation solution

[0031] Take DMEM / F12, DMSO and PBS, and prepare a basal culture medium according to the volume ratio of DMEM / F12:DMSO:PBS=50:10:40.

[0032] Astragalus extract, Scutellaria baicalensis extract, Lycium barbarum extract, and Plantago seed extract were added to the basal culture medium at a concentration of 5 mg / mL, 15 mg / mL, 30 mg / mL, 60 mg / mL, and 100 mg / mL to obtain freezing solutions containing plant extracts at different concentrations.

[0033] 4. Cryopreservation

[0034] Take the hUC-MSC culture flask of generation P3, discard the supernatant, rinse twice with PBS, add 1 mL of trypsin and digest at 37°C for 1 min, terminate the digestion, and collect the cells by centrifugation (300 rpm).

[0035] The cells were added to the freezing solution containing different concentrations of plant extracts to adjust the cell concentration to 1×10 6 / mL, packaged in cryopreservation tubes, first placed in a 4℃ refrigerator for precooling for 10 minutes, then cooled to -25℃ at a cooling rate of -1℃ / min, then accelerated to -80℃, and then directly placed in a -196℃ liquid bag for storage.

[0036] Samples were taken at the 12th, 24th and 30th months of storage to determine cell survival rates. The results are shown in Table 1.

[0037] Cell survival rate = (1-number of cells stained with trypan blue / number of frozen cells) × 100%, repeated 3 times and took the average.

[0038] Table 1 Cell viability of cryopreserved solutions containing different concentrations of plant extracts

[0039]

[0040]

[0041] Note: “-” in the table means that the previous measurement result was not ideal and was not measured.

[0042] As can be seen from Table 1, the Astragalus extract can effectively maintain cell activity within the concentration range of 5-100 mg / mL within 12 months of cryopreservation, but with the extension of cryopreservation time, the cell survival rate drops significantly and is not suitable for long-term storage. When the Scutellaria extract is added at 5 mg / mL and 15 mg / mL, the cryopreservation time of cells can be extended to 30 months, and the cell survival rate is relatively high. The protective effect of Lycium barbarum extract on cells is weak and is not suitable as an additive to the cryopreservation solution of mesenchymal stem cells. When the Plantago extract is added at 60 mg / mL, the cells are cryopreserved for 30 months, and the survival rate is still above 85%. In summary, Scutellaria extract and Plantago extract can significantly improve the cryopreservation survival rate of human umbilical cord mesenchymal stem cells and prolong the cryopreservation time at a specific addition amount.

[0043] After each sampling to determine the survival rate, the treatment group with a survival rate of more than 80% was selected for sampling and culture to observe the cell morphology and immunophenotype. The cells in the Astragalus, Scutellaria and Plantago groups after recovery had uniform morphology, long fusiform or spindle-shaped, and vortex-shaped growth. The cells in the Lycium barbarum group after recovery were wide and multi-angled, with branches. The immunophenotypes of each group after different freezing times were determined. The cells in the Scutellaria and Plantago groups after recovery highly expressed CD90 and CD44, and did not express or lowly expressed CD31, CD45, and HLA-DR.

[0044] It can be seen from the above embodiments that the present invention provides a cryopreservation solution for human umbilical cord mesenchymal stem cells, which improves the survival rate of hUC-MSCs and prolongs the cryopreservation time of hUC-MSCs by adding a specific concentration of plant extracts to a basic cryopreservation medium.

[0045] The above is only a preferred embodiment of the present invention. It should be pointed out that for ordinary technicians in this technical field, several improvements and modifications can be made without departing from the principle of the present invention. These improvements and modifications should also be regarded as the scope of protection of the present invention.

Claims

1. A human umbilical cord mesenchymal stem cell cryopreservation solution, characterized in that: Includes basal culture medium and plant extracts; The basic culture medium comprises DMEM / F12, DMSO and PBS, and the volume ratio of DMEM / F12, DMSO and PBS is 40-60:5-10:30-50; The plant extract is a scutellaria baicalensis extract or a plantain seed extract.

2. The human umbilical cord mesenchymal stem cell cryopreservation solution according to claim 1, characterized in that: The added amount of the scutellaria baicalensis extract is 5 to 20 mg / L of the volume of the basic culture medium.

3. The human umbilical cord mesenchymal stem cell cryopreservation solution according to claim 1, characterized in that: The amount of the plantago seed extract added is 50-70 mg / L of the volume of the basic culture medium.

4. The human umbilical cord mesenchymal stem cell cryopreservation solution according to claim 2 or 3, characterized in that: The preparation method of the scutellaria baicalensis extract or the plantain seed extract comprises the following steps: (1) soaking dried Scutellaria baicalensis root or dried Plantago asiatica seed in water, filtering out water after soaking, and grinding to obtain Scutellaria baicalensis root powder or Plantago asiatica seed powder; (2) adding water to a slurry of scutellaria baicalensis powder or a slurry of plantain seed powder and boiling the mixture, separating the solid from the liquid, and obtaining a filtrate; (3) The filtrate is concentrated and then dried to obtain a scutellaria baicalensis extract or a plantain seed extract.

5. The human umbilical cord mesenchymal stem cell cryopreservation solution according to claim 4, characterized in that: The amount of water added for the soaking is 5 to 10 times the mass of the dried root of Scutellaria baicalensis or the dried Plantago asiatica; and the soaking time is 6 to 8 hours.

6. The human umbilical cord mesenchymal stem cell cryopreservation solution according to claim 5, characterized in that: When adding water for decoction, the volume ratio of scutellaria baicalensis powder slurry or plantain seed powder slurry to water is 1:3-5, and the decoction time is 30-60 minutes.

7. Use of the cryopreservation solution according to any one of claims 1 to 6 in cryopreserving human umbilical cord mesenchymal stem cells.